Clinical Trial Update: The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection [NA]

View source ↗

Summary

A clinical trial update investigates whether adding Vitamin D to Pegylated Interferon alfa-2a or to Telbivudine therapy benefits patients with chronic hepatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Telbivudine (telbivudine)
• Vitamin D supplement (Vitamin D)

Snippet

Sponsor: Ziv Hospital | Conditions: Hepatitis B Virus | NA | Status: UNKNOWN